Precision medicine is a rapidly evolving field in cancer management and the use of novel molecular or genetic signatures in local-regional management is still in its infancy. Sharad Goyal, MD, professor of radiology at the George Washington University School of Medicine and Health Sciences, is tapping into this topic as the co-author/editor of “Precision Radiation Oncology,” a book demystifying new technologies and methods in the field.
The book describes current clinical and pathologic features and focuses on the ability to improve outcomes in cancer using radiation therapy. Readers will find discussion on incorporating novel genomic- or biology-based biomarkers in the treatment of patients moving radiation oncology into precision/personalized medicine.
“Since the field is changing so quickly, we wanted to give researchers an overview of the new developments in precision medicine as it applies to radiation oncology,” Goyal said.
Goyal has published over 100 manuscripts and a dozen book chapters, including publications in peer-reviewed journals such as the Journal of Clinical Oncology and the International Journal of Radiation Oncology. His research focuses on improving the quality of care received by cancer patients, both by advancing the ways in which cancer is treated with radiation and by integratiing data from epidemiological settings in cardiology and oncology to better inform treatment and survivorship issues among cardiology and cancer patients.
Published by Rutgers University Press Medicine, “Precision Radiation Oncology” was co-authored by Bruce G. Haffty, MD, professor and chair in the Department of Radiation Oncology at Rutgers – Robert Wood Johnson Medical School, along with contributions from several other authors.
